Skip to main content

DNA methylation markers predict recurrence-free interval in triple-negative breast cancer.

Publication ,  Journal Article
Fackler, MJ; Cho, S; Cope, L; Gabrielson, E; Visvanathan, K; Wilsbach, K; Meir-Levi, D; Lynch, CF; Marks, J; Geradts, J; Regan, MM; Viale, G ...
Published in: NPJ Breast Cancer
2020

We lack tools to risk-stratify triple-negative breast cancer (TNBC). Our goal was to develop molecular tools to predict disease recurrence. Methylation array analysis was performed on 110 samples treated by locoregional therapy obtained from institutional cohorts. Discovered marker sets were then tested by Kaplan-Meier analyses in a prospectively collected TNBC cohort of 49 samples from the no-chemotherapy arms of IBCSG trials VIII and IX, and by logistic regression in a chemotherapy-treated cohort of 121 TNBCs from combined IBCSG trials and institutional repositories. High methylation was associated with shorter recurrence-free interval in the no-chemotherapy arm of the IBCSG studies, as well as in the chemotherapy-treated patients within the combined institutional and IBCSG chemotherapy cohorts (100 marker panel, p = 0.002; 30 marker panel, p = 0.05). Chromosome 19 sites were enriched among these loci. In conclusion, our hypermethylation signatures identify increased recurrence risk independent of whether patients receive chemotherapy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

NPJ Breast Cancer

DOI

ISSN

2374-4677

Publication Date

2020

Volume

6

Start / End Page

3

Location

United States

Related Subject Headings

  • 4202 Epidemiology
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fackler, M. J., Cho, S., Cope, L., Gabrielson, E., Visvanathan, K., Wilsbach, K., … Umbricht, C. B. (2020). DNA methylation markers predict recurrence-free interval in triple-negative breast cancer. NPJ Breast Cancer, 6, 3. https://doi.org/10.1038/s41523-020-0145-3
Fackler, Mary Jo, Soonweng Cho, Leslie Cope, Edward Gabrielson, Kala Visvanathan, Kathleen Wilsbach, Danielle Meir-Levi, et al. “DNA methylation markers predict recurrence-free interval in triple-negative breast cancer.NPJ Breast Cancer 6 (2020): 3. https://doi.org/10.1038/s41523-020-0145-3.
Fackler MJ, Cho S, Cope L, Gabrielson E, Visvanathan K, Wilsbach K, et al. DNA methylation markers predict recurrence-free interval in triple-negative breast cancer. NPJ Breast Cancer. 2020;6:3.
Fackler, Mary Jo, et al. “DNA methylation markers predict recurrence-free interval in triple-negative breast cancer.NPJ Breast Cancer, vol. 6, 2020, p. 3. Pubmed, doi:10.1038/s41523-020-0145-3.
Fackler MJ, Cho S, Cope L, Gabrielson E, Visvanathan K, Wilsbach K, Meir-Levi D, Lynch CF, Marks J, Geradts J, Regan MM, Viale G, Wolff AC, Sukumar S, Umbricht CB. DNA methylation markers predict recurrence-free interval in triple-negative breast cancer. NPJ Breast Cancer. 2020;6:3.

Published In

NPJ Breast Cancer

DOI

ISSN

2374-4677

Publication Date

2020

Volume

6

Start / End Page

3

Location

United States

Related Subject Headings

  • 4202 Epidemiology
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences